These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8133796

  • 21. A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women.
    Bird HA, Burkinshaw L, Pearson D, Atkinson PJ, Leatham PA, Hill J, Raven A, Wright V.
    Ann Rheum Dis; 1987 Mar; 46(3):237-43. PubMed ID: 3555359
    [Abstract] [Full Text] [Related]

  • 22. Nandrolone decanoate for men with osteoporosis.
    Hamdy RC, Moore SW, Whalen KE, Landy C.
    Am J Ther; 1998 Mar; 5(2):89-95. PubMed ID: 10099043
    [Abstract] [Full Text] [Related]

  • 23. Effects of nandrolone decanoate (Decadurabolin) on serum Lp(a), lipids and lipoproteins in women with postmenopausal osteoporosis.
    Lippi G, Guidi G, Ruzzenente O, Braga V, Adami S.
    Scand J Clin Lab Invest; 1997 Oct; 57(6):507-11. PubMed ID: 9350070
    [Abstract] [Full Text] [Related]

  • 24. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E, Lyritis GP, Kosmidis C, Galanos A, Andypas G, Chorianopoulos K, Giagiosis A, Iliadou K, Karagianis A, Katsimichas K, Koskinas A, Matsouka K.
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [Abstract] [Full Text] [Related]

  • 25. Characterization of bone mineral composition in the proximal tibia of cynomolgus monkeys: effect of ovariectomy and nandrolone decanoate treatment.
    Huang RY, Miller LM, Carlson CS, Chance MR.
    Bone; 2002 Mar; 30(3):492-7. PubMed ID: 11882463
    [Abstract] [Full Text] [Related]

  • 26. [Effects of nandrolone decanoate on bone mineral content and intestinal absorption of calcium].
    Nuti R, Righi GA, Turchetti V, Vattimo A.
    Minerva Med; 1984 Jan 28; 75(3-4):109-13. PubMed ID: 6366617
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
    Johansen KL, Mulligan K, Schambelan M.
    JAMA; 1999 Apr 14; 281(14):1275-81. PubMed ID: 10208142
    [Abstract] [Full Text] [Related]

  • 30. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D.
    J Clin Endocrinol Metab; 1997 Feb 14; 82(2):620-8. PubMed ID: 9024265
    [Abstract] [Full Text] [Related]

  • 31. Long-term effect of nandrolone decanoate, 1 alpha-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study.
    Geusens P, Dequeker J.
    Bone Miner; 1986 Sep 14; 1(4):347-57. PubMed ID: 3333018
    [Abstract] [Full Text] [Related]

  • 32. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women.
    Rejnmark L, Buus NH, Vestergaard P, Heickendorff L, Andreasen F, Larsen ML, Mosekilde L.
    J Bone Miner Res; 2004 May 14; 19(5):737-44. PubMed ID: 15068496
    [Abstract] [Full Text] [Related]

  • 33. Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study.
    Gonnelli S, Cepollaro C, Montomoli M, Gennari L, Montagnani A, Palmieri R, Gennari C.
    Clin Endocrinol (Oxf); 1997 Jan 14; 46(1):55-61. PubMed ID: 9059558
    [Abstract] [Full Text] [Related]

  • 34. Virilization of the voice in post-menopausal women due to the anabolic steroid nandrolone decanoate (Decadurabolin). The effects of medication for one year.
    Gerritsma EJ, Brocaar MP, Hakkesteegt MM, Birkenhäger JC.
    Clin Otolaryngol Allied Sci; 1994 Feb 14; 19(1):79-84. PubMed ID: 8174308
    [Abstract] [Full Text] [Related]

  • 35. Effects of protein-rich supplementation and nandrolone on bone tissue after a hip fracture.
    Tengstrand B, Cederholm T, Söderqvist A, Tidermark J.
    Clin Nutr; 2007 Aug 14; 26(4):460-5. PubMed ID: 17498850
    [Abstract] [Full Text] [Related]

  • 36. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.
    Strawford A, Barbieri T, Neese R, Van Loan M, Christiansen M, Hoh R, Sathyan G, Skowronski R, King J, Hellerstein M.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb 01; 20(2):137-46. PubMed ID: 10048900
    [Abstract] [Full Text] [Related]

  • 37. Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass.
    Gennari C, Adami S, Agnusdei D, Bufalíno L, Cervetti R, Crepaldi G, Di Marco C, Di Munno O, Fantasia L, Isaia GC, Mazzuoli GF, Ortolani S, Passeri M, Serni U, Vecchiet L.
    Calcif Tissue Int; 1997 Feb 01; 61 Suppl 1():S19-22. PubMed ID: 9263612
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.